Avanos Medical, Inc.

$24.74-0.04%($-0.01)
TickerSpark Score
70/100
Solid
87
Valuation
35
Profitability
70
Growth
60
Health
100
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AVNS research report →

52-Week Range99% of range
Low $9.30
Current $24.74
High $24.91

Companyavanos.com

Avanos Medical, Inc. , a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands.

CEO
David C. Pacitti
IPO
2014
Employees
2,227
HQ
Alpharetta, GA, US

Price Chart

+88.85% · this period
$24.81$17.35$9.89May 20Nov 18May 20

Valuation

Market Cap
$1.16B
P/E
-16.54
P/S
1.62
P/B
1.47
EV/EBITDA
-66.55
Div Yield
0.00%

Profitability

Gross Margin
48.55%
Op Margin
-7.92%
Net Margin
-9.69%
ROE
-8.91%
ROIC
-6.03%

Growth & Income

Revenue
$701.20M · 1.95%
Net Income
$-67,900,000 · 82.68%
EPS
$-1.46 · 82.88%
Op Income
$-61,600,000
FCF YoY
-48.01%

Performance & Tape

52W High
$24.91
52W Low
$9.30
50D MA
$19.42
200D MA
$13.93
Beta
1.59
Avg Volume
1.32M

Get TickerSpark's AI analysis on AVNS

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
May 8, 26BLACKFORD GARYother12,003
May 8, 26Egbuonu-Davis Lisaother12,003
May 8, 26Franchini Indrani Lallother12,003
May 8, 26OLEARY PATRICK Jother12,003
May 8, 26Shimer Julie Annother12,003
Apr 22, 26Galovan Scott Michaelother4,228
Apr 22, 26Delgado Sigfridoother4,264
Apr 14, 26Pacitti Davidother21,194
Mar 13, 26Delgado Sigfridoother37,782
Mar 13, 26Pacitti Davidother241,021

Our AVNS Coverage

We haven't published any research on AVNS yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate AVNS Report →

Similar Companies